Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Determine the Immunomodulatory Effect of Probiotics on the Immunogenicity of Anti-SARS-CoV-2 Vaccine Recipients Study.

NCT07610512 is registered in ClinicalTrials.gov with Grape King Bio Ltd. as lead sponsor.

NCT NCT07610512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07610512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Determine the Immunomodulatory Effect of Probiotics on the Immunogenicity of Anti-SARS-CoV-2 Vaccine Recipients Study.
Lead sponsor
Grape King Bio Ltd.
Phase
Not applicable
Overall status
Completed
Start date
October 13, 2021
Completion date
March 31, 2022
Enrollment
138 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, immune response